Atria Wealth Solutions Inc. decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,162 shares of the medical research company’s stock after selling 105 […]